CymitQuimica logo

CAS 83015-26-3

:

Atomoxetine

Description:
Atomoxetine is a selective norepinephrine reuptake inhibitor (NRI) primarily used in the treatment of attention deficit hyperactivity disorder (ADHD). It is characterized by its chemical formula, which includes a phenyl ring and a secondary amine, contributing to its pharmacological properties. Atomoxetine is known for its ability to increase norepinephrine levels in the brain, thereby enhancing attention and reducing impulsivity and hyperactivity in individuals with ADHD. The substance is typically administered orally and has a relatively long half-life, allowing for once-daily dosing in many cases. Atomoxetine is not classified as a controlled substance, distinguishing it from other ADHD medications that may have stimulant properties. Its side effects can include gastrointestinal issues, fatigue, and changes in mood, but it is generally well-tolerated. The compound's mechanism of action and its non-stimulant nature make it a valuable option for patients who may not respond well to traditional stimulant medications.
Formula:C17H21NO
InChI:InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1
InChI key:InChIKey=VHGCDTVCOLNTBX-QGZVFWFLSA-N
SMILES:[C@@H](OC1=C(C)C=CC=C1)(CCNC)C2=CC=CC=C2
Synonyms:
  • (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine
  • (R)-Atomoxetine
  • (R)-N-Methyl-gamma-(2-methyl-phenoxy)benzenepropanamine
  • (R)-Tomoxetine
  • (γR)-N-Methyl-γ-(2-methylphenoxy)benzenepropanamine
  • Atomoxetine
  • Benzenepropanamine, N-methyl-γ-(2-methylphenoxy)-, (R)-
  • Benzenepropanamine, N-methyl-γ-(2-methylphenoxy)-, (γR)-
  • N-Methyl-3-(2-Methylphenoxy)Benzenepropanamine
  • (-)-Tomoxetine
  • Tomoxetine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.